+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Ursodeoxycholic acid prevents steroid resistant rejection in liver transplant recipients



Ursodeoxycholic acid prevents steroid resistant rejection in liver transplant recipients



Gastroenterology 108(4 Suppl. ): A1168




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 034144884

Download citation: RISBibTeXText

DOI: 10.1016/0016-5085(95)28972-0


Related references

Adjuvant ursodeoxycholic acid prevents acute rejection in liver transplant recipients. Transplantation Proceedings 23(3): 1971, 1991

Evidence that ursodeoxycholic acid prevents steroid-resistant rejection in adult liver transplantation. Clinical Transplantation 10(6 Pt 2): 658-662, 1996

Ursodeoxycholic acid for prevention of acute rejection in liver transplant recipients. Lancet 336(8706): 52-53, 1990

Does adjuvant ursodeoxycholic acid prevent early rejection in liver transplant recipients. Gastroenterology 98(5 Part 2): A587, 1990

Conversion from cyclosporine to tacrolimus prevents transplant function loss due to acute steroid-resistant or chronic rejection in renal allograft recipients. Transplantation Proceedings 33(7-8): 3161-3163, 2001

OKT3 treatment of steroid-resistant rejection in pediatric liver transplant recipients. Journal of Pediatric Gastroenterology and Nutrition 14(1): 86-91, 1992

Treatment of steroid-resistant rejection with tacrolimus prior to OKT3 in liver transplant recipients. Transplantation Proceedings 28(2): 1014, 1996

A comparison of outcomes between OKT3 and antithymocyte globulin for treatment of steroid-resistant rejection in hepatitis C liver transplant recipients. Transplantation 97(4): 470-473, 2014

Methotrexate for lung transplant recipients with steroid-resistant acute rejection. Journal of Heart and Lung Transplantation 15(11): 1130-1137, 1996

Enhanced risk of steroid-resistant acute rejection following pretransplant steroid therapy in liver graft recipients. Transplantation 60(10): 1104-1108, 1995

The effect of ursodeoxycholic acid of liver transplant rejection in the rat. Clinical & Investigative Medicine 16(4 Suppl. ): B139, 1993

Use of antithymocyte globulin and cyclosporine to treat steroid-resistant rejection episodes in renal transplant recipients. Transplantation Proceedings 19(1 Pt 3): 1889-1891, 1987

Antithymocyte globulin for steroid resistant rejection in renal transplant recipients immunosuppressed with triple therapy. Transplant International 2(1): 27-32, 1989

Antilymphoblast globulin treatment of steroid-resistant rejection in cyclosporine-immunosuppressed renal transplant recipients. Transplantation Proceedings 19(1 Pt 3): 1892, 1987

Cyclosporin A pharmacokinetics in liver transplant recipients effect of ursodeoxycholic acid. Gastroenterology 118(4 Suppl 2 Part 1): AASLD A984, 2000